Literature DB >> 357144

Bombesin inhibits insulin release from isolated pancreatic islets of rats in vitro.

T Taminato, Y Seino, Y Goto, S Matsukura, H Imura, N Sakura, N Yanaihara.   

Abstract

The effect of bombesin on insulin release from isolated pancreatic islets of rats was examined in vitro. Bombesin, at the doses ranging from 10 ng/ml to 1 microgram/ml, significantly inhibited 16.7 mM glucose-induced insulin release, while bombesin had no inhibitory effect on insulin release at 8.3 mM and 3.3 mM glucose. Moreover, bombesin also suppressed insulin release elicited by 10 mM arginine at the doses of 100 ng/ml and 1 microgram/ml. These results indicate that bombesin has a direct inhibitory action on insulin release.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 357144     DOI: 10.1507/endocrj1954.25.305

Source DB:  PubMed          Journal:  Endocrinol Jpn        ISSN: 0013-7219


  3 in total

1.  Opposite effects of bombesin on insulin and gastrin response to food in humans.

Authors:  C Scarpignato; B Micali
Journal:  Gut       Date:  1986-05       Impact factor: 23.059

2.  Bombesin stimulates insulin secretion by a pancreatic islet cell line.

Authors:  S L Swope; A Schonbrunn
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

3.  The EndoC-βH1 cell line is a valid model of human beta cells and applicable for screenings to identify novel drug target candidates.

Authors:  Violeta Georgieva Tsonkova; Fredrik Wolfhagen Sand; Xenia Asbæk Wolf; Lars Groth Grunnet; Anna Kirstine Ringgaard; Camilla Ingvorsen; Louise Winkel; Mark Kalisz; Kevin Dalgaard; Christine Bruun; Johannes Josef Fels; Charlotte Helgstrand; Sven Hastrup; Fredrik Kryh Öberg; Erik Vernet; Michael Paolo Bastner Sandrini; Allan Christian Shaw; Carsten Jessen; Mads Grønborg; Jacob Hald; Hanni Willenbrock; Dennis Madsen; Rasmus Wernersson; Lena Hansson; Jan Nygaard Jensen; Annette Plesner; Tomas Alanentalo; Maja Borup Kjær Petersen; Anne Grapin-Botton; Christian Honoré; Jonas Ahnfelt-Rønne; Jacob Hecksher-Sørensen; Philippe Ravassard; Ole D Madsen; Claude Rescan; Thomas Frogne
Journal:  Mol Metab       Date:  2017-12-19       Impact factor: 7.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.